Literature DB >> 33371279

Aqueous Extracts of Morus alba Root Bark and Cornus officinalis Fruit Protect against Osteoarthritis Symptoms in Testosterone-Deficient and Osteoarthritis-Induced Rats.

Sunmin Park1,2, Bo Reum Moon1, Ji Eun Kim1, Hyun Joo Kim1, Ting Zhang1,2.   

Abstract

Water extracts of both Morus alba L. root bark (MBW) and Cornus officinalis Siebold and Zucc fruit (CFW) have traditionally been used to promote men's health in the elderly in Asia. We determined that the 12-week consumption of MBW and CFW could alleviate testosterone-deficiency syndrome and osteoarthritis (OA) symptoms in testosterone-deficient rats, and the action mechanisms were explored. Rats with bilateral orchiectomy (ORX) were fed a 45% fat diet containing either 0.5% MBW (ORX-MBW), 0.5% CFW(ORX-CFW), or 0.5% dextrin (ORX-CON). Sham-operated rats also received 0.5% dextrin (Non-ORX-CON). After 8 weeks of treatment, all rats had an injection of monoiodoacetate (MIA) into the left knee, and they continued the same diet for the additional 4 weeks. ORX-CFW and ORX-MBW partially prevented the reduction of serum testosterone concentrations and decreased insulin resistance, compared to the ORX-CON. ORX-CFW and ORX-MBW protected against the reduction of bone mineral density (BMD) and lean body mass (LBM) compared to the ORX-CON. The limping and edema scores were lower in the order of the ORX-CON, ORX-CRF = ORX-MBW, and Non-ORX-CON (p < 0.05). The scores for pain behaviors, measured by weight-distribution on the OA leg and maximum running velocity on a treadmill, significantly decreased in the same order as limping scores. ORX-MBW protected against the increased expression of matrix metalloproteinase (MMP)-3 and MMP-13 and reduced the production of inflammatory markers such as TNF-α and IL-1β, by MIA in the articular cartilage, compared to the ORX-CON (p < 0.05). The cartilage damage near the tidemark of the knee and proteoglycan loss was significantly less in ORX-MBW than ORX-CON. In conclusion, MBW, possibly CFW, could be effective alternative therapeutic agents for preventing osteoarthritis in testosterone-deficient elderly men.

Entities:  

Keywords:  articular cartilage; bone mineral density; inflammation; lean body mass; pain behavior; testosterone deficiency

Year:  2020        PMID: 33371279      PMCID: PMC7767081          DOI: 10.3390/pharmaceutics12121245

Source DB:  PubMed          Journal:  Pharmaceutics        ISSN: 1999-4923            Impact factor:   6.321


  3 in total

Review 1.  Active Components and Pharmacological Effects of Cornus officinalis: Literature Review.

Authors:  Xue Gao; Yi Liu; Zhichao An; Jian Ni
Journal:  Front Pharmacol       Date:  2021-04-12       Impact factor: 5.810

2.  Protection against Osteoarthritis Symptoms by Aerobic Exercise with a High-Protein Diet by Reducing Inflammation in a Testosterone-Deficient Animal Model.

Authors:  Sunmin Park; Suna Kang; Da Sol Kim; Ting Zhang
Journal:  Life (Basel)       Date:  2022-01-26

3.  Antiosteoarthritic Effect of Morroniside in Chondrocyte Inflammation and Destabilization of Medial Meniscus-Induced Mouse Model.

Authors:  Eunkuk Park; Chang Gun Lee; Seong Jae Han; Seung Hee Yun; Seokjin Hwang; Hyoju Jeon; Jeonghyun Kim; Chun Whan Choi; Siyoung Yang; Seon-Yong Jeong
Journal:  Int J Mol Sci       Date:  2021-03-15       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.